NEW YORK (GenomeWeb News) – Ariana Pharma announced today an exclusive distribution deal with CTC Laboratory Systems covering Japan.
The terms of the deal call for CTCLS to distribute Ariana's KEM data analytics software and services technology. CTCLS, based in Tokyo, is an R&D service provider, specializing in the pharmaceutical sector.
Further details of the deal were not disclosed.
KEM, short for Knowledge Extraction and Management, is an association rules-based data analytical technology. It finds patient responder "subpopulations and biomarker signatures that statistical methods are unable to detect," according to Ariana, which has offices in Paris and in Cambridge, Mass.
"This deal with CTCLS will provide an excellent entry into Asia and the world's third largest biotechnology market," Mohammad Afshar, president and CEO of Ariana, said in a statement. "We expect the ongoing growth of Japanese companies in medicine development, diagnostics, and biomarker studies will further increase demand for Ariana’s KEM software."